FDA Regulatory Bottlenecks Threaten Survival of SMEs
Bureaucratic bottlenecks and high regulatory costs at the Food and Drugs Authority (FDA) are crippling small- and medium-sized enterprises (SMEs), discouraging them from obtaining sanitary permits and product approvals—raising both public health concerns and questions




